Bachrodt Amy sold MAZE
February 2, 2026 · Form 4 insider transaction
Bachrodt Amy sold 200 shares of Maze Therapeutics, Inc. at $44.15 per share, a transaction worth $8.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$44.15
Total value
$8.8K
InsiderBachrodt Amy
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 2, 2026
Filing dateFebruary 4, 2026
Shares owned after17,765
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.